• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Gsk Plc ADR (NY: GSK )

    44.88 -0.44 (-0.97%)
    Official Closing Price Updated: 7:00 PM EDT, May 16, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,666,361
    Open 45.12
    Bid (Size) 44.36 (1)
    Ask (Size) 45.34 (1)
    Prev. Close 45.32
    Today's Range 44.82 - 45.20
    52wk Range 33.33 - 45.92
    Shares Outstanding 5,385,189,617
    Dividend Yield 3.22%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
    On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France,... 
    Via Benzinga
    Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
    The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics. 
    Via InvestorPlace
    Topics Intellectual Property
    Exposures Intellectual Property

    Performance

    YTD
    +19.65%
    +19.65%
    1 Month
    +12.34%
    +12.34%
    3 Month
    +7.45%
    +7.45%
    6 Month
    +30.31%
    +30.31%
    1 Year
    +24.18%
    +24.18%

    More News

    Read More
    Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
    Via InvestorPlace
    Amazon Pours ~$1.3B Investment Into French Operations: Report
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
    Via Benzinga
    Exposures Product Safety
    Moderna Dives Back Into Buy Zone After FDA Delays Its RSV Vaccine
    Via Investor's Business Daily
    Exposures Product Safety
    Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
    Via Benzinga
    Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Moderna Puts Up Big Quarterly Beat; Could Shares Notch A Breakout?
    Via Investor's Business Daily
    7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
    Via InvestorPlace
    GSK Stock Earnings: GSK Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
    Via Benzinga
    Forget the Fed. These 3 Stocks Will Soar No Matter What
    Via InvestorPlace
    Topics Economy
    Exposures Interest Rates
    COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
    Via Benzinga
    Topics Intellectual Property Lawsuit
    Exposures COVID-19 Financial Intellectual Property
    Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    What's Going On With Pfizer Stock On Thursday?
    Via Benzinga
    Topics Intellectual Property
    Exposures COVID-19 Intellectual Property
    Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges
    Via Benzinga
    Topics Brexit
    Exposures Brexit
    Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future
    Via Benzinga
    GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years
    Via Benzinga
    Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields
    Via Benzinga
    Down 75%. Is Agenus Stock a Buy on the Dip?
    Via The Motley Fool
    CureVac, GS Partner Release Data On Influenza Vaccine Study
    Via Benzinga
    In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
    Via Benzinga
    Topics Lawsuit
    Exposures Financial Legal
    Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
    Via MarketBeat
    Exposures Product Safety
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.